KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Progyny (PGNY) EBT (2018 - 2025)

Progyny (PGNY) has disclosed EBT for 8 consecutive years, with $17.9 million as the latest value for Q4 2025.

  • Quarterly EBT rose 1.11% to $17.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.4 million through Dec 2025, up 14.7% year-over-year, with the annual reading at $95.4 million for FY2025, 14.7% up from the prior year.
  • EBT for Q4 2025 was $17.9 million at Progyny, down from $24.0 million in the prior quarter.
  • The five-year high for EBT was $27.1 million in Q2 2025, with the low at -$398000.0 in Q4 2021.
  • Average EBT over 5 years is $15.3 million, with a median of $16.7 million recorded in 2023.
  • The sharpest move saw EBT plummeted 133.84% in 2021, then surged 11600.7% in 2023.
  • Over 5 years, EBT stood at -$398000.0 in 2021, then skyrocketed by 1140.45% to $4.1 million in 2022, then soared by 292.71% to $16.3 million in 2023, then increased by 8.58% to $17.7 million in 2024, then increased by 1.11% to $17.9 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $17.9 million, $24.0 million, and $27.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.